Using both liquid and tissue biopsies to guide targeted treatment may improve outcomes in patients with solid tumor malignancies.

Merck announced plans to acquire Verona Pharma for roughly $10 billion. 1 As part of the agreement between the two companies, Merck will add Verona’s COPD treatment Ohtuvayre to its cardio-pulmonary ...

The startup is using elements of gene and cell therapy to create medicines that could be useful against an array of ...

Pomerantz joins as an independent director. The company is advancing a novel technology platform, based on the first ever ...

Backed by an initial funding of $15 million from the National Science Foundation, the Regenerative Medicine Engine is the ...

The global 3D bioprinting market is set to witness a growth rate of 12-15% in the next 5 years. Rising demand for organ ...

The FDA has accepted for priority review a new supplemental biologics license application for Winrevair to treat adults with ...

There's one main way to treat inflammatory bowel disease (IBD): Control inflammation by whipping the immune system into shape, a process that can go haywire or fail to work. But what if the body could ...

Schistosomiasis (SCH) and soil-transmitted helminthiasis (STH) are among the world’s most persistent neglected tropical diseases (NTDs) — a group of conditions that disproportionately affect the world ...

The global cell culture market is projected to grow at a CAGR of 12% from 2025 to 2030. This growth is driven by increasing ...

EXCLUSIVE: New mum Zara was shattered when told she had bowel cancer, but a new drug trial at The Christie in Manchester has ...

Three young Triangle-based medical technology companies with roots in Duke University research labs are getting major global attention from their industry. They’re among the 65 cutting-edge companies ...